Clinical Trials · NCT03204396
Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- University Hospital, Basel, Switzerland
- Enrollment
- 256
- Start date
- Jun 2017
- Locations
- 1 site, Switzerland
- Primary endpoint
- Point prevalence abstinence rate at week 12